Tenafly, NJ, United States of America

Jeffrey P Bergman


Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 247(Granted Patents)


Location History:

  • Ridgefield Park, NJ (US) (1995 - 1997)
  • Telford, PA (US) (1998 - 1999)
  • Tenafly, NJ (US) (1999 - 2002)

Company Filing History:


Years Active: 1995-2002

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey P. Bergman

Introduction

Jeffrey P. Bergman is a notable inventor based in Tenafly, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, Bergman has made strides in developing compounds that target various health conditions, particularly those related to metabolic disorders.

Latest Patents

Bergman's latest patents include innovative derivatives of arylthiazolidinedione and aryloxazolidinedione. These substituted 5-aryl-2,4-thiazolidinediones and oxazolidinediones serve as potent agonists of PPAR (Peroxisome Proliferator-Activated Receptors). They are particularly useful in the treatment, control, or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR α and/or γ mediated diseases, disorders, and conditions.

Career Highlights

Bergman is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on the development of innovative therapeutic solutions that address critical health issues. His expertise in medicinal chemistry and pharmacology has been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Bergman has collaborated with esteemed colleagues, including Soumya P. Sahoo and Richard L. Tolman. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical products.

Conclusion

Jeffrey P. Bergman's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving health outcomes. His work continues to influence the treatment of various metabolic disorders, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…